We first tested the association between HLA types and irAEs of different organs in our ICI treatment cohort (nominally significant HLA variants shown in Figure 4 ), then validated this association by comparing the frequency of HLA types between participants with irAEs and the Novegene cancer reference cohort and the healthy MHC-Han Chinese reference cohort.
1
—
—